FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q2 2020

Type / Class
Equity / SHS
Symbol
FOMX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q2 0 $0 -$81,000 0
2020 Q1 0 $0 -$94,827,789 0
2019 Q4 28,609,337 $95,252,795 -$3,273,002 $3.33 63
2019 Q3 28,905,157 $87,868,000 +$4,327,999 $3.04 58
2019 Q2 28,785,806 $68,507,868 -$6,667,154 $2.38 56
2019 Q1 30,671,539 $115,018,600 -$6,364,225 $3.75 61
2018 Q4 32,461,009 $115,644,829 -$18,589,840 $3.59 64
2018 Q3 34,347,476 $196,812,971 +$57,962,230 $5.73 76
2018 Q2 24,205,802 $121,270,575 +$18,717,135 $5.01 54
2018 Q1 21,442,876 $109,995,475 -$2,087,446 $5.13 56
2017 Q4 21,611,870 $129,896,080 +$721,800 $6.01 47
2017 Q3 21,495,149 $119,579,032 -$1,045,446 $5.55 44
2017 Q2 21,913,894 $101,905,916 -$5,571,403 $4.64 54
2017 Q1 22,741,126 $112,580,161 -$8,436,174 $4.95 62
2016 Q4 24,101,814 $267,527,000 +$15,550 $11.10 64
2016 Q3 23,978,703 $222,045,656 +$66,950,137 $9.26 62
2016 Q2 16,965,352 $107,726,821 -$7,154,258 $6.35 55
2016 Q1 18,058,821 $117,733,682 +$1,538,852 $6.52 66
2015 Q4 17,701,261 $143,558,769 +$2,655,691 $8.11 70
2015 Q3 17,284,766 $126,699,183 +$5,565,885 $7.33 73
2015 Q2 16,030,496 $164,315,155 +$89,386,376 $10.25 83
2015 Q1 7,426,545 $68,697,000 +$20,858,991 $9.25 31
2014 Q4 5,353,776 $37,531,000 +$7,225,145 $7.01 20
2014 Q3 4,357,648 $23,747,000 +$23,747,000 $5.45 19